The ultimate outcome of the clinical trials and research efforts of the BPCA program is a change in a medication label to improve the knowledge and safe use of that drug in the pediatric population.

In addition to a label change, there are other avenues for sharing BPCA-supported resources with researchers, health care providers, and the public, including publications, training opportunities, lectures, collaborations, and working group recommendations and presentations. ​